MK6070-003: A Phase 1b/2 Open-label Study Evaluating different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-based regimens in First-line Extensive Stage Small Cell Lung Cancer

Objective

Clinical Trial Details

Principal Investigator(s)

Amy N. Sanford, MD

Clinical Trial Categories

• Cancer
• Lung Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org